A platform from 2460 Health TechVisit 2460.life
Knowledge Base

The field, in reference form.

96 articles across the donation pathway, donor types, allocation and policy, law and ethics, and the workforce that carries the work. Public, free, and reviewed by named professionals. Educational reference, not medical advice.

Want to contribute or suggest a correction? Authoring lives in the Meira app.

The donation pathway (the spine)

The end-to-end deceased-donation process: referral, evaluation, authorization, donor management, recovery, preservation and transport, allocation, transplantation, and follow-up. Every clinical, workforce, and policy article is locatable against a pathway stage.

Donor types

Deceased donation (DBD, DCD, NRP); living donation (directed, non-directed, paired exchange); and donor-quality concepts such as KDPI/KDRI.

Solid organs

Kidney, liver, heart, lung, pancreas, and intestine/multivisceral transplantation.

Vascularized composite allotransplantation (VCA)

Hand and face transplantation (also uterus, abdominal wall). Added to the OPTN definition of organ effective July 3, 2014; restorative rather than life-saving.

Tissue and eye banking

Cornea, skin, bone and musculoskeletal tissue, heart valves, vessels, and amniotic membrane; tissue banks; eye banks; and FDA HCT/P regulation.

Transplant immunology

HLA and tissue typing, the crossmatch, PRA/cPRA, ABO compatibility, donor-specific antibodies, rejection, immunosuppression, GVHD, and tolerance.

Allocation and policy

OPTN policy, the match run, MELD, KDPI, continuous distribution and the Composite Allocation Score, organ-specific allocation, geographic distribution, and the waiting list.

Law and ethics

NOTA, the UAGA, the UDDA and brain death, the dead donor rule, consent models, financial neutrality, the Declaration of Istanbul, and trafficking.

Actors and institutions

OPOs, transplant centers, the OPTN, UNOS, the SRTR, HRSA, HLA laboratories, tissue and eye banks, and donor registries.

Workforce and roles

The donation-and-transplantation workforce organized by pathway stage and cross-cutting function across OPOs, transplant centers, tissue banks, eye banks, and HLA laboratories.

Public health, epidemiology, and the donation gap

The waiting list, annual transplant volume, the supply-demand shortage, registries, and Donate Life America.

History and milestones

Murray 1954, Barnard 1967, Starzl, the cyclosporine era, and NOTA 1984.

Global and comparative systems

Spain and the ONT, the UK and NHSBT, Eurotransplant, the WHO Guiding Principles, and the evidence on opt-out versus opt-in.

Patient- and donor-family-facing

How to register, what can be donated, the recipient journey, donor-family aftercare and bereavement, and common myths and FAQs.